Logo

American Heart Association

  2
  0


Final ID: Su3045

Coronary Artery Calcium Scans Powered by Artificial Intelligence (AI-CAC) Predicts Atrial Fibrillation and Stroke Comparably to Cardiac Magnetic Resonance Imaging: The Multi-Ethnic Study of Atherosclerosis (MESA)

Abstract Body (Do not enter title and authors here): Background: Coronary artery calcium (CAC) scans contain more actionable information than the Agatston CAC score. We have previously shown in the Multi-Ethnic Study of Atherosclerosis (MESA) that AI-enabled left atrial (LA) volumetry in CAC scans (AI-CAC) enabled prediction of atrial fibrillation (AF) as early as one year. Furthermore, we have recently shown adding AI-CAC LA volumetry to CHA2DS2-VASc risk score improved stroke prediction in MESA. In this study we evaluated the performance of AI-CAC LA volumetry versus LA measured by human experts using cardiac magnetic resonance imaging (CMRI) for predicting AF and stroke, and compared them with CHARGE-AF risk score, Agatston score, and NT-proBNP.
Methods: We used 15-year outcomes data from 3552 asymptomatic individuals (52.2% women, age 61.7±10.2 years) who underwent both CAC scans and CMRI in the MESA baseline examination. We have applied the AutoChamberTM (HeartLung.AI, Houston, TX) component of AI-CAC to 3552 CAC scans. CMRI LA volume was previously measured by human experts. Data on NT-proBNP, CHARGE-AF risk score and the Agatston score were obtained from MESA. Discrimination was assessed using the time-dependent area under the curve (AUC).
Results: Over 15 years follow-up, 562 cases of AF and 140 cases of stroke accrued. The AUC for 15-year AF prediction by AI-CAC LA volume (0.801) was comparable to CMRI LA volume (0.797) and significantly higher than Agatston CAC Score (0.687) and NT-proBNP (0.704). Similarly, the AUC for 15-year stroke prediction for AI-CAC volumetry (0.761) was comparable to CMRI volumetry (0.751) and significantly higher than NT-proBNP (0.631) and Agatston CAC Score (0.646). AI-CAC LA volume outperformed CHARGE AF over 1-3 years for incident AF (p<0.02), but not for subsequent years. AI-CAC significantly improved the continuous Net Reclassification Index (NRI) for prediction of AF and stroke when added to CHARGE-AF risk score (0.28, 0.21), NT-proBNP (0.43, 0.37), and Agatston score (0.69, 0.41) respectively (p for all<0.0001).
Conclusion: LA volumetry measured by the AutoChamber component of AI-CAC and CMRI LA volume measured by human experts similarly predicted incident AF and stroke over 15 years, and outperformed NT-proBNP and Agatston CAC Score. AI-CAC LA volumetry outperformed CHARGE-AF and NT-proBNP for short-term (1-3 years) AF prediction. Further studies to investigate the clinical utility of AI-CAC LA volumetry for AF and stroke prediction are warranted.
  • Naghavi, Morteza  ( HeartLung.AI , Houston , Texas , United States )
  • Wong, Nathan  ( University of California, Irvine, , Irvine , California , United States )
  • Reeves, Anthony  ( Cornell University , Ithaca , New York , United States )
  • Atlas, Kyle  ( HeartLung.AI , Houston , Texas , United States )
  • Zhang, Chenyu  ( HeartLung.AI , Houston , Texas , United States )
  • Atlas, Thomas  ( Tustin Teleradiology , Tustin , California , United States )
  • Henschke, Claudia  ( Mount Sinai Hospital , New York , New York , United States )
  • Roy, Sion  ( Lundquist Institute at Harbor UCLA , Malibu , California , United States )
  • Budoff, Matthew  ( Lundquist Institute at Harbor UCLA , Malibu , California , United States )
  • Yankelevitz, David  ( Mount Sinai Hospital , New York , New York , United States )
  • Author Disclosures:
    Morteza Naghavi: DO have relevant financial relationships ; Ownership Interest:HeartLung.AI:Active (exists now) | Nathan Wong: No Answer | Anthony Reeves: No Answer | Kyle Atlas: DO have relevant financial relationships ; Independent Contractor:HeartLung.AI:Active (exists now) | Chenyu Zhang: DO have relevant financial relationships ; Employee:HeartLung Corporation:Active (exists now) ; Individual Stocks/Stock Options:HeartLung Corporation:Active (exists now) | Thomas Atlas: DO NOT have relevant financial relationships | Claudia Henschke: No Answer | Sion Roy: DO NOT have relevant financial relationships | Matthew Budoff: DO have relevant financial relationships ; Researcher:General Electric:Active (exists now) | David Yankelevitz: DO have relevant financial relationships ; Individual Stocks/Stock Options:HeartLung:Active (exists now) ; Advisor:Lunglife AI:Active (exists now) ; Advisor:Carestream:Active (exists now) ; Advisor:Median Technology:Active (exists now) ; Advisor:HeartLung:Active (exists now) ; Individual Stocks/Stock Options:Accumetra:Active (exists now) ; Royalties/Patent Beneficiary:General Electric:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

AI at Heart: Revolutionizing Cardiovascular Imaging

Sunday, 11/17/2024 , 11:30AM - 12:30PM

Abstract Poster Session

More abstracts on this topic:
Bisphosphonate therapy improves bone deficits but worsens arterial calcification in Mgp-null mice

Soheili Fariborz, Heydarikhorneh Niloufar, Rotstein Benjamin, Chen Hsiao-huei, Stewart Alexandre

A Novel EMR-Based Algorithm with the Virtual Echocardiography Screening Tool (VEST) to Screen Patients for Pulmonary Arterial Hypertension

Narowska Gabriela, Anand Suneesh, Gangireddy Chethan, Enevoldsen John, Keane Martin, Edmundowicz Daniel, Forfia Paul, Vaidya Anjali

More abstracts from these authors:
Automated Left Ventricular Volumetry using Artificial Intelligence in Coronary Calcium Scans (AI-CAC) Predicts Heart Failure Comparably to Cardiac MRI and Outperforms NT-proBNP: The Multi-Ethnic Study of Atherosclerosis (MESA)

Naghavi Morteza, Wong Nathan, Levy Daniel, Reeves Anthony, Atlas Kyle, Zhang Chenyu, Atlas Thomas, Budoff Matthew, Roy Sion, Henschke Claudia, Yankelevitz David

AI-enabled Cardiac Chambers Volumetry in Non-Contrast Cardiac CT scans (AI-CAC) Detects HFrEF vs. HFpEF

Naghavi Morteza, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Jaalouk Emily, Henschke Claudia, Yankelevitz David, Roy Sion, Budoff Matthew

You have to be authorized to contact abstract author. Please, Login
Not Available